Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Marie Skłodowska-Curie Action · Running

SHINE-Vax Smart Hydrogel Microneedle Patches for mRNA Nanoparticle Vaccination

Coordinator
Karolinska Institutet, Sweden
Runs
1 September 2027 to 31 August 2029
Status
Running
EU funding
€236k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101274031

What the project is doing

In the project's own words, from its summary on CORDIS.

The COVID-19 pandemic highlighted the transformative potential of mRNA vaccines, yet their delivery remains confined to intramuscular injections, which cause discomfort, reduce compliance, and rely on cold-chain logistics. Microneedle patches offer a minimally invasive alternative, but current systems mainly provide single-burst, fixed-dose release, limiting safety and efficacy. This project, SHINE-Vax, develops a temperature-responsive hydrogel microneedle system for controlled mRNA vaccine delivery.

Dual hydrogel layers with distinct phase transitions enable an initial release pulse at normal body temperature (~37 °C), sustained low-dose diffusion to reinforce immunity, and reversible suppression under fever-like conditions (~39 °C). Encapsulated lipid/polymer nanoparticles preserve mRNA integrity and stability, reducing cold-chain dependence. By integrating materials engineering, nanotechnology, and vaccine science, SHINE-Vax will deliver a proof-of-concept prototype (TRL 2–3) demonstrating autonomous, adaptive release.

This innovation aims to enhance vaccine efficacy and safety while broadening accessibility, particularly in resource-limited settings, positioning Europe at the forefront of next-generation, patient-friendly vaccination technologies.

Topics

Who is involved

OrganisationCityCountryRole
Karolinska InstitutetStockholmSwedenCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI